In conclusion, our study finds a previously unknown T cell exhaustion–associated target at the single-cell level and reveals mechanisms by which HMGB2 impairs mitochondrial OXPHOS in CD8+ T cells and inhibits IFN-γ response in tumor cells, thus inducing immune evasion of HCC. Here, HMGB2 is linked to neoplasm.